Skip to search formSkip to main contentSkip to account menu

metastatic malignant melanoma

Known as: malignant melanoma metastatic 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Role of circulating angiogenin TGF-β1, VEGF-R1, and VEGF-R2 in metastatic malignant melanoma patients.
9048 Background: Malignant melanoma is a disease capable of rapid progression and is associated with high angiogenesis. Thus… 
2010
2010
An open-label, multicenter, phase III trial of nab-paclitaxel (NP) versus dacarbazine (DTIC) in previously untreated patients (PTs) with metastatic malignant melanoma (MMM).
TPS314 Background: Nab-paclitaxel (Abraxane; NP) a Cremophor-free, nanoparticle albumin formulation of paclitaxel targets albumin… 
2008
2008
Phase II trial of combination thalidomide (thal) plus temozolomide (TMZ [TT]), in patients with metastatic malignant melanoma (MMM): Southwest Oncology Group S0508
9007 Background: In single institution phase II studies, combination TT has yielded response rates (RR) up to 32% in the… 
2005
2005
Open-label, multicenter, phase II trial of ABI-007 in previously treated and previously untreated patients with metastatic malignant melanoma
7558 Background: ABI-007 (Abraxane TM), is an albumin-bound, nanoparticle form of paclitaxel with an improved therapeutic index… 
2005
2005
Relationship of soluble VEGF-C and VEGF-D with clinicopathological parameters in metastatic malignant melanoma patients treated by biochemotherapy
7540 Background and Objectives: Angiogenesis is essential for tumor growth & metastasis. It is controlled by angiogenic factors… 
2004
2004
Phase 2 study of PS-341 (bortezomib) in the treatment of metastatic malignant melanoma (MMM).
7526 Background: PS-341 is an agent that appeared to have anti-melanoma properties in pre-clinical studies both in vitro and in… 
2001
2001
Melanoma antigen expression in serial fine‐needle aspiration samples in patients with metastatic malignant melanoma participating in immunotherapy clinical trials
MART‐1 and gp100 currently are utilized as targets in immunotherapy protocols for metastatic malignant melanoma (MMM). Enrollment… 
1993
1993
MDR-1 expression in metastatic malignant melanoma.
Metastatic malignant melanoma (MMM) carries an ominous prognosis. This poor prognosis is due in part to the remarkable resistance… 
1993
1993
Oxygen tension measurements in human tumors: The institut gustave-roussy experience
Tumor hypoxia contributes to the response to radiotherapy and to chemotherapy. The oxygenation status of normal tissues and… 
1992
1992
Fotemustine — an advance in the treatment of metastatic malignant melanoma
Although chemotherapy has been generally of limited clinical benefit in the treatment of metastatic malignant melanoma (MMM… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)